Weather alert: Due to Hurricane Ian, there may be delays in receiving and processing samples. You can still place orders on our website, which we will fulfill as soon as possible. Please reach out to clientservices@sema4.com if you have any questions.

Comprehensive NF Panel

New York
Approved


Genes

NF1, NF2, SMARCB1, SPRED1

Conditions

  • Legius Syndrome
  • Neurofibromatosis Type 1
  • Neurofibromatosis Type 2
  • Schwannomatosis

Clinical Utility

  • Establish or confirm a clinical diagnosis Identification of at-risk family members
  • Development of an appropriate evaluation and management
  • Prenatal diagnosis for known familial mutation(s) in at-risk pregnancies

Lab Method

  • Deletion/Duplication Analysis
  • MLPA
  • Next-Gen Sequencing

Test Code

961

CPT Codes*

81405x2, 81406x1, 81408x1

ABN Required

No

Turnaround Time**

3 weeks

Preferred Specimen

2-5 mL Blood - Lavender Top Tube

Alternative Specimen

Buccal Swabs

*The CPT codes provided are based on AMA guidelines and are for informational purposes only. CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payer being billed.

**Reporting times are typical and begin once the sample(s) are received at the GeneDx laboratory, but could be extended in situations outside GeneDx’s reasonable control.